Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01511016 · ClinicalTrials.gov registry record · NA
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
A NA study of HIV Lipodystrophy, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT01511016 is a NA study of HIV Lipodystrophy that has completed, run by Baylor College of Medicine. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01511016, a NA study of HIV Lipodystrophy, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
"HIV lipodystrophy syndrome" (HLS) is characterized by loss of fat in the arms and legs, with increase in fat in the abdomen, and abnormal blood lipid levels. Persons with HLS have high risk for cardiovascular disease and diabetes mellitus and the metabolic syndrome. The investigators have previously shown that the abnormal lipid levels and lipodystrophy in HLS are associated with defective regulation of lipid metabolic rates, specifically, accelerated lipolysis (breakdown of stored fats), and decreased fat oxidation (utilization of fats for energy). Patients with HLS also have low levels of the hormone leptin. The investigators hypothesize that treatment of these patients with leptin will improve fat oxidation and may slow the rate of lipolysis. Hence, the investigators propose to study the effect of leptin therapy on lipid metabolic rates and lipid and glucose levels in adults with HLS. The investigators will use state of the art stable isotope tracer techniques and gas chromatography mass spectrometry (GCMS) to measure lipolysis, fat oxidation, and fat re-esterification in adipose tissues and liver.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Human recombinant leptin ("metreleptin")
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2003-02 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01511016
The ClinicalTrials.gov registry entry for NCT01511016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Lipodystrophy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01511016 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01511016 about?
NCT01511016 is a clinical study titled "Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome". "HIV lipodystrophy syndrome" (HLS) is characterized by loss of fat in the arms and legs, with increase in fat in the abdomen, and abnormal blood lipid levels. Persons with HLS have high risk for cardiovascular disease and diabetes mellitus and the metabolic syndrome. The investigators have previousl...
What is the current status of trial NCT01511016?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2003-02. Estimated completion is 2011-10.
What conditions does trial NCT01511016 study?
This clinical trial studies the following conditions: HIV Lipodystrophy.
What interventions are being tested in trial NCT01511016?
The interventions under investigation include: Placebo (DRUG), Human recombinant leptin ("metreleptin") (DRUG).
Who is sponsoring clinical trial NCT01511016?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01511016 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Lipodystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.